Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review

Current guidelines for patients with acute coronary syndrome (ACS) recommend dual antiplatelet therapy (DAPT) for 12 months. Since bleeding is the main Achilles' heel of DAPT, in recent years several randomized controlled trials have evaluated the safety and efficacy of de-escalation of DAPT wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Farag, Mohamed, Jeyalan, Visvesh, Ferreiro, Jose Luis, Jeong, Young-Hoon, Geisler, Tobias, Gorog, Diana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630649/
https://www.ncbi.nlm.nih.gov/pubmed/36337887
http://dx.doi.org/10.3389/fcvm.2022.1018649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630649/
https://www.ncbi.nlm.nih.gov/pubmed/36337887
http://dx.doi.org/10.3389/fcvm.2022.1018649

Ejemplares similares